Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BB3 (ANG-3777) for Delayed Graft Function in Kidney Transplant
NCT01286727Phase 2Unknown
- Sponsor
- Angion Biomedica Corp.
- Start
- Feb 2010
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of terevalefim in delayed graft function (DGF), sponsored by Angion Biomedica Corp.. Status: unknown.
02
Drugs
terevalefim
03
Conditions
delayed graft function (DGF)
Beyond the preview
Go deeper on NCT01286727.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01286727.